ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 52 filers reported holding ATYR PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $454,000 | -38.4% | 211,356 | -8.8% | 0.00% | -100.0% |
Q3 2016 | $737,000 | +8.5% | 231,813 | -5.2% | 0.00% | 0.0% |
Q2 2016 | $679,000 | +11216.7% | 244,405 | +14820.9% | 0.00% | – |
Q1 2016 | $6,000 | -62.5% | 1,638 | 0.0% | 0.00% | – |
Q4 2015 | $16,000 | -48.4% | 1,638 | -46.5% | 0.00% | – |
Q3 2015 | $31,000 | -45.6% | 3,061 | 0.0% | 0.00% | – |
Q2 2015 | $57,000 | – | 3,061 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |